Delivery Order SPE2DB25D3021-SPE2DB25FQZBB
- Not listed
- The Defense Logistics Agency awarded a $1,837.60 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Nucynta 50 mg tablets (100-count packages). This firm fixed-price contract, which is not set-aside and competitively awarded, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is the company's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $10,441.56 to AmerisourceBergen Drug Corp for Nucynta Tabs 50mg on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The order, valued at $3,601.04, is for the supply of 100mg tablets of the pain medication Nucynta. The delivery order falls under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with DLA, which has a maximum potential value of $999,999,999.00 and a performance...
- This delivery order, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation, has a potential value of $507 to supply 100 tablets of 50mg Nucynta. The place of performance is in Conshohocken, Pennsylvania. No set-aside designation was used for this firm fixed price order, which must be completed by October 20, 2023. As the Defense Logistics Agency is responsible for procuring pharmaceuticals and medical supplies for the U.S. military and other government agencies, this...
- The Defense Logistics Agency awarded a delivery order valued at $3,816.36 to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 100 mg tablets in quantities of 100 units. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by July 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the award from its corporate office location. This...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,311.84, is for the supply of 100 units of the medication NUCYNTA 50 MG TABLET. The award has an ultimate completion date of June 21, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 100 mg NUCYNTA tablets. The $41,724.51 contract has a completion date of July 16, 2025 and is not set aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a wide range of pharmaceutical products and medical supplies in support of military and...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,850.41 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This contract is for the delivery of 4,563,980,877 tablets of the prescription medication NUCYNTA 50 MG. The period of performance extends through March 18, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $1,592.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 60 tablets of the pain medication NUCYNTA ER 50 mg. The contract is a firm fixed-price delivery order with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,837.56 firm fixed-price delivery order is for the supply of NUCYNTA 50 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of March 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- SPE2DB25D3021Indefinite Delivery Contract
- SPE2DB25D3021-SPE2DB25FQZBBDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,347.68 for 100 tablets of Nucynta 50 mg on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. Nucynta is a pain management pharmaceutical used across military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitively awarded contracts across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/21/25 |